In vitro and in vivo studies demonstrated that circPLEKHM3 played an anti-tumor role by sponging miR-9 to enhance the tumor-suppressive effect of BRCA1, DNAJB6, and KLF4, and consequently inactivated the AKT signaling in EOC. This evidence concerns the gene BRCA1 and neoplasm.